| Print
Nkarta (NKTX)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Nkarta Inc Second Quarter Earnings Results for 2026 | 2026-08-12T00:00:00 |
| Nkarta Inc Annual General Meeting for 2026 | 2026-06-05T13:00:00 |
| Nkarta Inc First Quarter Earnings Results for 2026 | 2026-05-14T00:00:00 |
| Nkarta Inc Fourth Quarter Earnings Results for 2025 | 2026-03-26T00:00:00 |
| Nkarta Inc Annual Report for 2025 | 2026-03-26T00:00:00 |
| Nkarta Inc Third Quarter Earnings Results for 2025 | 2025-11-07T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| H.C. Wainwright 27(th) Annual Global Investment Conference | 2025-09-09T08:30:00 |
| Nkarta Inc Second Quarter Earnings Results for 2025 | 2025-08-12T00:00:00 |
| Nkarta Inc Annual General Meeting for 2025 | 2025-06-05T13:00:00 |
| Nkarta Inc First Quarter Earnings Results for 2025 | 2025-05-14T00:00:00 |
| 24th Annual Needham Virtual Healthcare Conference | 2025-04-08T11:00:00 |
| Nkarta Inc Fourth Quarter Earnings Results for 2024 | 2025-03-26T00:00:00 |
| Nkarta Inc Annual Report for 2024 | 2025-03-26T00:00:00 |
| Leerink Partners 2025 Global Healthcare Conference | 2025-03-10T15:00:00 |
| TD Cowen 45th Annual Health Care Conference | 2025-03-03T15:10:00 |
| Nkarta 7(th) Annual Evercore HealthCONx Conference 2024 | 2024-12-04T14:10:00 |
| Stifel 2024 Healthcare Conference | 2024-11-19T10:55:00 |
| Nkarta Inc Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.